Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

The federal judge's ruling that the Affordable Care Act is unconstitutional is one more reminder about the history of predictions on the health care law: the track record is pretty embarrassing.

The big picture: Few legal experts took the Texas lawsuit seriously when it was filed in February, so they didn't see it as a threat to the law. Turns out it is. And that's just the latest in a long series of ACA predictions that didn't hold up.

  • It'll be just like Social Security and Medicare. Democrats misjudged the strength of the Republican opposition to the law — and the protests around the country — when they pushed it through Congress in 2010. Fine, they said, but Social Security and Medicare also faced opposition when they were created, and now everybody loves them. The ACA was different — in no small part because Democrats passed it without a single Republican vote.
  • "Jobs killer." That's what Republicans labeled the law in 2010, and the prediction lived on for years. It's hard for economists to know for sure what would have happened without the law, but the jobs market isn't exactly hurting now, with the law still in place.
  • 24 million people. That's how many people were supposed to get their health insurance through the ACA's marketplaces in 2021, according to the Congressional Budget Office's original estimates. That's still a few years away, but as of 2018, the actual enrollment was a little over 10 million.
  • "If you like your health care plan, you can keep it." Barack Obama's famous line was promise and prediction, rolled into one. It didn't work out that way for a few million people whose individual health insurance plans didn't meet ACA standards.
  • Trump wins — the ACA is getting repealed. Remember when Donald Trump's election was going to change everything? It didn't.
  • If you kill the individual mandate, you kill the ACA. That was the Obama administration's argument to the Supreme Court in 2012: the popular parts of the law, including protections for pre-existing conditions, only work if there's a mandate to make sure healthy people get insurance and pay for sick people. But since Congress got rid of the tax penalty, making the mandate unenforceable, enrollment has only dropped a bit.

What to watch: Now, legal experts across the board are saying the federal judge's ruling that wipes out the ACA is too silly to be upheld. And maybe they're right — maybe it will be reversed by the Fifth Circuit Court of Appeals, or if not, by the Supreme Court. But given the track record of ACA predictions, don't bet your house on it.

Go deeper:

Go deeper

Ben Geman, author of Generate
1 hour ago - Energy & Environment

Democrats' clean power outlook is very muddy

Illustration: Annelise Capossela/Axios

Here are two big questions as a key Democratic proposal to slash emissions from power generation flounders: how much its demise would sap climate protections, and what might replace it.

Catch up fast: New financial carrots and sticks for utilities to deploy zero-carbon power — the Clean Electricity Performance Program (CEPP) — look unlikely to stay in Democrats' big social spending and climate bill.

Colin Powell dies from COVID complications at 84

Photo: Paul Morigi/Getty Images for Capital Concerts

Colin Powell, the first Black U.S. secretary of state, died of complications from COVID-19, his family announced Monday. He was 84.

Driving the news: The Powell family said in a statement that he was fully vaccinated. He had undergone treatment for multiple myeloma, a type of blood cancer that can weaken the immune system, a spokesperson confirmed to Axios.

3 hours ago - Health

This arthritis drug cost $198 in 2008. Now it's more than $10,000

Illustration: Aïda Amer/Axios

In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.

Why it matters: As federal lawmakers continue to waver on drug price reforms, Indocin is another example of how nothing prevents drug companies from hiking prices at will and selling them within a broken supply chain.